Q3 EPS Estimates for Henry Schein Increased by Analyst

Henry Schein, Inc. (NASDAQ:HSIC) – Stock analysts at Barrington Research upped their Q3 2025 earnings per share (EPS) estimates for Henry Schein in a research report issued on Wednesday, February 26th. Barrington Research analyst M. Petusky now expects that the company will post earnings of $1.30 per share for the quarter, up from their previous estimate of $1.22. Barrington Research currently has a “Outperform” rating and a $90.00 target price on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.04). The firm had revenue of $3.19 billion during the quarter, compared to analysts’ expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.66 EPS.

Several other brokerages have also issued reports on HSIC. Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday, November 7th. UBS Group cut their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the company from $69.00 to $84.00 in a research note on Monday, January 6th. Finally, Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 price objective for the company. Six analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Up 0.1 %

Shares of HSIC opened at $72.17 on Friday. The firm has a market cap of $9.00 billion, a P/E ratio of 29.70, a P/E/G ratio of 2.13 and a beta of 0.91. The stock has a 50 day simple moving average of $74.35 and a two-hundred day simple moving average of $72.42. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.49.

Hedge Funds Weigh In On Henry Schein

A number of hedge funds and other institutional investors have recently made changes to their positions in HSIC. Palestra Capital Management LLC bought a new position in shares of Henry Schein during the fourth quarter valued at approximately $182,988,000. Lyrical Asset Management LP bought a new position in shares of Henry Schein during the fourth quarter valued at approximately $126,655,000. Norges Bank bought a new position in shares of Henry Schein during the fourth quarter valued at approximately $103,301,000. Steadfast Capital Management LP raised its holdings in shares of Henry Schein by 254.2% during the fourth quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after acquiring an additional 1,175,408 shares in the last quarter. Finally, ING Groep NV bought a new position in shares of Henry Schein during the third quarter valued at approximately $63,226,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.